Global T-Cell Immunotherapy Pipeline Analysis, 2016 – Clinical Trials & Results, Patent, Designation, Collaboration … – PR Newswire (press release)
|
Global T–Cell Immunotherapy Pipeline Analysis, 2016 – Clinical Trials & Results, Patent, Designation, Collaboration …
PR Newswire (press release) T-cell immunotherapy mainly consists of T-cell receptor (TCR), Tumor-infiltrating lymphocytes (TILs) and Chimeric antigen receptors (CAR) T-cell therapy. TCR is a complex integral membrane protein that activates T-cells in response to an antigen. |
